The impact of turmeric or its curcumin extract on nonalcoholic fatty liver disease: a systematic review of clinical trials | Zendy

C Michael White | Zendy; JiYoung Lee | Zendy

Open Access

The impact of turmeric or its curcumin extract on nonalcoholic fatty liver disease: a systematic review of clinical trials

Author(s) -

C Michael White,

JiYoung Lee

Publication year - 2019

Publication title -

pharmacy practice

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.608

H-Index - 24

eISSN - 1886-3655

pISSN - 1885-642X

DOI - 10.18549/pharmpract.2019.1.1350

Subject(s) - curcumin , medicine , placebo , nonalcoholic fatty liver disease , clinical trial , alanine transaminase , traditional medicine , randomized controlled trial , curcuminoid , fatty liver , gastroenterology , transaminase , aspartate transaminase , pharmacology , disease , pathology , alternative medicine , biology , alkaline phosphatase , biochemistry , enzyme

Curcumin extract is a promising, but not proven, treatment for NAFLD while the role for turmeric is less clear. The general findings are that ALT, AST and NAFLD severity are reduced with the use of curcumin.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research